1. Neher A et al. Tolerability of N-chlorotaurine in the guinea pig middle ear – a pilot study using an improved application system. Ann Otol Rhino Larygol. 2004; 113: 76-81.
  2. Neher A et al. Acute Otitus Externa: Efficacy and Tolerability of N-Chlorotaurine, a Novel Endogenous Antiseptic Agent. Laryngoscope. 2004; 114: 850-854.


  1. Cegolon L et al. Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents. Int J Hyg Environ Health. 2020; 230: 113605.
  2. Neher A et al. Antimicrobial activity of dexamethasone and its combination with N-chlorotaurine. Arch Otolaryngol Head Neck Surg. 2008; 134(6): 615-620.
  3. Arnitz R et al. A novel N-chlorotaurine-corticosteroid combination as a preservative-free local disinfectant: Influence on the ciliary beat frequency in vitroActa Oto-Laryngologica. 2006; 126: 291-294.
  4. Neher A et al. Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter. Auris Nasus Larynx. 2005; 32: 359-364.
  5. Gstöttner M et al. Refractory Rhinosinusitis Complicating Immunosuppression: Application of N-Chlorotaurine, a Novel Endogenous Antiseptic Agent. ORL J Otorhinolaryngol Relat Spec. 2003; 65: 303-305.
  6. Hofer E et al. In vitro study on the influence of N-chlorotaurine on the ciliary beat frequency of nasal mucosa. Am J Rhinol. 2003; 17: 149-152.
  7. Nagl M et al. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother. 2001; 47(6): 871-874.


  1. Lorenz K et al. Effect of N-chlorotaurine mouth rinses on plaque regrowth and plaque vitality. Clin. Oral Investig. 2009; 13(1): 9-14.